Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma

Journal of Neurotrauma

Volumn 22, Issue 5, 2005, Pages 518-528

  Hohenstein, Axel ^a   Erber, Ralf ^a   Schilling, Lothar ^a   Weigel, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenic disease; Angiopoetines; Chronic subdural hematoma (CSH); Cytokines; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC CODE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MALE; NEUTROPHIL; OUTER MEMBRANE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBDURAL HEMATOMA;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BLOOD VESSELS; FEMALE; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; RECEPTOR, TIE-2; RECURRENCE; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 19444385681     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.518     Document Type: Article

References (47)

1. AIELLO, L.P., AVERY, R.L., ARRIGG, P.G., et al. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480-1487.
2. BARLEON, B., SIEMEISTER, G., MARTINY-BARON, G., WEINDEL, K., HERZOG, C., and MARME, D. (1997). Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res. 57, 5421-5425.
3. CHEN, J.C., and LEVY, M.L. (2000). Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg. Clin. North Am. 11, 399-406.
4. CHOI, S.J., PARK, J.Y., LEE, Y.K., et al. (2002). Effects of cytokines on VEGF expression and secretion by human first trimester trophoblast cell line. Am. J. Reprod. Immunol. 48, 70-76.
5. DAMERT, A., MACHEIN, M., BREIER, G., et al. (1997). Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57, 3860-3864.
6. DIAZ-FLORES, L., GUTIERREZ, R., and VARELA, H. (1994). Angiogenesis: an update. Histol. Histopathol. 9, 807-843.
7. FERRARA, N. (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
8. FERRARA, N., GERBER, H.P., and LECOUTER, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
9. FRIEDE, R.L., and SCHACHENMAYR, W. (1978). The origin of subdural neomembranes II. Fine structure of neomembranes. Am. J. Pathol. 92, 69-78.
10. FUJISAWA, H., NOMURA, S., TSUCHIDA, E., and ITO, H. (1998). Serum protein exudation in chronic subdural haematomas: a mechanism for haematoma enlargement? Acta Neurochir. (Wien) 140, 161-166.
11. GUNSILIUS, E., PETZER, A., STOCKHAMMER, G., et al. (2000). Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology 58, 169-174.
12. ITO, H., SAITO, K., YAMAMOTO, S., and HAWEGAWA, T. (1988). Tissue-type plasminogen activator in the chronic subdural hematoma. Surg. Neurol. 30, 175-179.
13. ITO, H., YAMAMOTO, S., KOMAI, T., and MIZUKOSHI, H. (1976). Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma. J. Neurosurg. 45, 26-31.
14. JELKMANN, W. (2001). Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin. Chem. 47, 617-623.
15. JONES, N., ILJIN, K., DUMONT, D.J., and ALITALO, K. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2, 257-267.
16. KASAMA, T., KOBAYASHI, K., YAJIMA, N., et al. (2000). Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA). Clin. Exp. Immunol. 121, 533-538.
17. KOEHNE, P., WILLAM, C., STRAUSS, E., SCHINDLER, R., ECKARDT, K.U., and BUHRER, C. (2000). Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am. J. Physiol. Heart Circ. Physiol. 279, H817-H824.
18. KOSTELIJK, E.H., FIJNHEER, R., NIEUWENHUIS, H.K., GOUWEROK, C.W., and DE KORTE, D. (1996). Soluble P-selectin as parameter for platelet activation during storage. Thromb. Haemost. 76, 1086-1089.
19. KREMER, C., BREIER, G., RISAU, W., and PLATE, K.H. (1997). Up-regulation of flk-1/vascular endothelial growth factor receptor-2 by its ligand in a cerebral slice culture system. Cancer Res. 57, 3852-3859.
20. LEIBOVITZ, A., BAUMOHL, Y., SEGAL, R., and HABOT, B. (2001). Age-associated neovasculopathy with recurrent bleeding. Med. Hypotheses 57, 616-618.
21. LOH, J.K., and HOWNG, S.L. (1998). Electron microscopic study on the outer membrane of chronic subdural hematoma. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 14, 25-30.
22. MANDRIOTA, S.J., and PEPPER, M.S. (1998). Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83, 852-859.
23. MARTI, H.J., BERNAUDIN, M., BELLAIL, A., et al. (2000). Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156, 965-976.
24. MATSUMOTO, M., SAKATA, Y., YAMAZAKI, T., ENDO, G., OHISHI, H., and TAKASU, N. (1999). Local coagulofibrinolysis in the postsurgical recovery of patients with chronic subdural haematoma. Acta Neurochir. (Wien) 141, 177-181.
25. MENON, C., IYER, M., PRABAKARAN, I., CANTER, R.J., LEHR, S.C., and FRAKER, D.L. (2003). TNF-alpha down-regulates vascular endothelial Flk-1 expression in human melanoma xenograft model. Am. J. Physiol. Heart Circ. Physiol. 284, H317-H329.
26. MORI, K., MITSUOKA, H., CHO, K., TAJIMA, A., and MAEDA, M. (1996). Rate constant of gadolinium (Gd)-DTPA transfer into chronic subdural hematomas. Neurol. Res. 18, 126-134.
27. NAKAMURA, S., and TSUBOKAWA, T. (1989). Extraction of angiogenesis factor from chronic subdural haematomas. Significance in capsule formation and haematoma growth. Brain Inj. 3, 129-136.
28. NEUFELD, G., TESSLER, S., GITAY-GOREN, H., COHEN, T., and LEVI, B.Z. (1994). Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res. 5, 89-97.
29. PARK, J.E., KELLER, G.A., and FERRARA, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326.
30. SAITO, K., ITO, H., HASEGAWA, T., and YAMAMOTO, S. (1989). Plasmin-alpha 2-plasmin inhibitor complex and alpha 2-plasmin inhibitor in chronic subdural hematoma. J. Neurosurg. 70, 68-72.
31. SARKAR, C., LAKHTAKIA, R., GILL, S.S., SHARMA, M.C., MAHAPATRA, A.K., and MEHTA, V.S. (2002). Chronic subdural haematoma and the enigmatic eosinophil. Acta Neurochir. (Wien) 144, 983-988.
32. SCHACHENMAYR, W., and FRIEDE, R.L. (1978). The origin of subdural neomembranes. I. Fine structure of the dura-arachnoid interface in man. Am. J. Pathol. 92, 53-68.
33. SHEN, B.Q., LEE, D.Y., GERBER, H.P., KEYT, B.A., FERRARA, N., and ZIONCHECK, T.F. (1998). Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem. 273, 29979-29985.
34. SHONO, T., INAMURA, T., MORIOKA, T., et al. (2001). Vascular endothelial growth factor in chronic subdural haematomas. J. Clin. Neurosci. 8, 411-415.
35. SOKER, S., SVAHN, C.M., and NEUFELD, G. (1993). Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem. 268, 7685-7691.
36. STOODLEY, M., and WEIR, B. (2000). Contents of chronic subdural hematoma. Neurosurg. Clin. North Am. 11, 425-434.
37. SUZUKI, K., TAKANO, S., NOSE, T., DOI, M., and OHASHI, N. (1999). Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J. Trauma 46, 532-533.
38. SUZUKI, M., ENDO, S., INADA, K., et al. (1998). Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir. (Wien) 140, 51-55.
39. THURSTON, G., RUDGE, J.S., IOFFE, E., et al. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463.
40. TISCHER, E., MITCHELL, R., HARTMAN, T., et al. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
41. VAQUERO, J., ZURITA, M., and CINCU, R. (2002). Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir. (Wien) 144, 343-346.
42. WEBB, N.J., MYERS, C.R., WATSON, C.J., BOTTOMLEY, M.J., and BRENCHLEY, P.E. (1998). Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10, 254-257.
43. WEIGEL, R., SCHILLING, L., and SCHMIEDEK, P. (2001). Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir. (Wien) 143, 811-818.
44. WEIGEL, R., SCHMIEDEK, P., and KRAUSS, J.K. (2003). Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J. Neurol. Neurosurg. Psychiatry 74, 937-943.
45. WERTHER, K., CHRISTENSEN, I.J., and NIELSEN, H.J. (2002). Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand. J. Clin. Lab. Invest. 62, 343-350.
46. YAMASHIMA, T., YAMAMOTO, S., and FRIEDE, R.L. (1983). The role of endothelial gap junctions in the enlargement of chronic subdural hematomas. J. Neurosurg. 59, 298-303.
47. YANCOPOULOS, G.D., DAVIS, S., GALE, N.W., RUDGE, J.S., WIEGAND, S.J., and HOLASH, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.